# Dextroamphetamine Sulfate Extended-Release

NDC: 0406-8961
Generic name: dextroamphetamine sulfate
Labeler / Manufacturer: SpecGx LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20030506

FDA application: ANDA076353

## Active ingredients

- DEXTROAMPHETAMINE SULFATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0406-8961"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0406-8961
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69c40af8-3710-46bf-bd3d-137fe5eea23e